MedPath

Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis

Phase 4
Completed
Conditions
Tranexamic Acid
Nasal Packing
Epistaxis
Interventions
Device: Merocel
Drug: Normal saline
Registration Number
NCT03360045
Lead Sponsor
Kecioren Education and Training Hospital
Brief Summary

Aim of this study is evaluate whether superior nasal compression with tranexamic acid to simple nasal compression and Merocel packing.

In this study, patients who presented with non-traumatic anterior epistaxis to emergency departments will be included in this study. Three different therapy option are created; first, nasal compression with tranexamic acid, second, simple nasal compression without any drugs. And third, packing with Merocel.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
135
Inclusion Criteria
  • Patients with anterior epistaxis older than 18 year and accept to participate in the study
Exclusion Criteria
  • Patients younger than 18 years
  • Patients who used anticoagulation therapy
  • Patients who have hemodynamically instability
  • Traumatic epistaxis
  • Patients who have known bleeding disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Merocel GroupMerocelMerocel packing is applied.
Placebo groupNormal saline5ml normal saline is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.
Tranexamic acid groupTranexamic Acid500mg tranexamic acid is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.
Primary Outcome Measures
NameTimeMethod
Numbers of patients who needs rescue treatmentAfter 15 minutes first intervention method.

In patients who have unstoppable epistaxis within 15 minutes, Merocel packing will be applied as a rescue treatment. Numbers of these patients will be recorded.

Success rate of interventions to stop bleedingFirst 15 minutes

Percentages of numbers of patients who have stopped bleeding within first 15 minutes after nasal compression or Merocel packing

Secondary Outcome Measures
NameTimeMethod
Re-bleeding24 hour

Frequency of re-bleeding within first 24 hours.

Trial Locations

Locations (1)

Keçiören Training and Research Hospital

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath